Northwestern Medicine Completes First Endobronchial Valve Procedure
Northwestern Medicine's Palos Hospital recently conducted its first endobronchial valve procedure using Pulmonx's Zephyr EBV system.Â
Northwestern Medicine's Palos Hospital recently conducted its first endobronchial valve procedure using Pulmonx's Zephyr EBV system.Â
Northwestern Medicine’s Palos Hospital recently conducted its first endobronchial valve procedure using Pulmonx’s Zephyr EBV system.Â
Read MoreLong-term data confirmed the Zephyr Endobronchial Valve provided improvements over baseline in lung function and quality of life out to at least 24 months, and improvements in exercise capacity out to at least 18 months.
Read MoreA new valve therapy that involves minimally invasive surgery could be a solution for patients with advanced COPD, who are breathless at rest, according to a report from The University of Michigan.
Read MoreThe Zephyr Endobronchial Valve is the first minimally-invasive device approved in the United States for treating patients with severe emphysema.
Read MoreAccording to new data, emphysema patients treated with Zephyr Endobronchial Valves had improved breathing, quality of life, and activity, Pulmonx reports.
Read More